Company research
APPLIED GENETIC TECHNOLOGIES CORP
CIK 1273636Updated Nov 16, 2026
Securities
Historical securities (1)
AGTC · NASDAQ · equity · closed Dec 1, 2022AGTC price & chart
Historical security
This listing closed Dec 1, 2022. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 66,684,000Source | 126,966,000Source | 100,319,000Source | 92,216,000Source |
| Property, Plant and Equipment, NetUSD | 4,714,000Source | 4,658,000Source | 4,311,000Source | 4,430,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 1,433,000Source | 1,287,000Source | 1,098,000Source | 1,013,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 46,366,000Source | 105,052,000Source | 38,463,000Source | 26,703,000Source |
| Assets, CurrentUSD | 49,561,000Source | 109,707,000Source | 82,964,000Source | 84,284,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,195,000Source | 2,655,000Source | 2,506,000Source | 2,276,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,043,000Source | 3,167,000Source | 3,422,000Source | — |
| Other Assets, NoncurrentUSD | 126,000Source | 113,000Source | 348,000Source | 544,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 37,207,000Source | 41,158,000Source | 29,303,000Source | 13,507,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 51,000Source | 43,000Source | 25,000Source | 18,000Source |
| Retained Earnings (Accumulated Deficit)USD | -308,212,000Source | -239,269,000Source | -181,440,000Source | -135,548,000Source |
| Stockholders' Equity Attributable to ParentUSD | 29,477,000Source | 85,808,000Source | 71,016,000Source | 78,709,000Source |
| Additional Paid in Capital, Common StockUSD | 337,894,000Source | 325,245,000Source | 252,519,000Source | 214,324,000Source |
| Liabilities and EquityUSD | 66,684,000Source | 126,966,000Source | 100,319,000Source | 92,216,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 25,207,000Source | 19,714,000Source | 12,963,000Source | 9,355,000Source |
| Operating Lease, Liability, CurrentUSD | 1,271,000Source | 1,116,000Source | 1,058,000Source | — |
| Accounts Payable, CurrentUSD | 2,911,000Source | 1,879,000Source | 1,355,000Source | 1,331,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,780,000Source | 3,418,000Source | 4,070,000Source | — |
| Other Liabilities, NoncurrentUSD | 98,000Source | 299,000Source | 2,555,000Source | 4,152,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 107,100,000Source | 80,500,000Source | 82,000,000Source |
| Long-term DebtUSD | 9,122,000Source | 17,727,000Source | 9,677,000Source | — |
| Long-term Debt, Current MaturitiesUSD | 9,298,000Source | 2,181,000Source | — | — |
| Short-term InvestmentsUSD | — | 2,000,000Source | 41,995,000Source | 55,292,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -45,892,000Source | -2,006,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 1,512,000Source | 1,460,000Source | 1,335,000Source | 1,273,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,425,000Source | 2,678,000Source | 2,998,000Source | 4,029,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 991,000Source | 497,000Source | 83,000Source | 327,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -65,748,000Source | -51,173,000Source | -41,620,000Source | -23,457,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -14,000Source | 38,147,000Source | 8,399,000Source | 19,027,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,670,000Source | 1,457,000Source | 943,000Source | 163,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 7,076,000Source | 79,615,000Source | 44,981,000Source | 68,000Source |
| Repayments of Long-term DebtUSD | 2,181,000Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -58,686,000Source | 66,589,000Source | 11,760,000Source | -4,362,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,977,000Source | 1,346,000Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 3,425,000Source | 2,678,000Source | 2,998,000Source | 4,029,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 693,000Source | 381,000Source | — | — |
| Amortization of Intangible AssetsUSD | 205,000Source | 182,000Source | 170,000Source | 163,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | 107,100,000Source | 80,500,000Source | 82,000,000Source |
| DepreciationUSD | 1,300,000Source | 1,300,000Source | 1,200,000Source | 1,100,000Source |
| General and Administrative ExpenseUSD | 16,985,000Source | 14,551,000Source | 13,617,000Source | — |
| Income (Loss) from Equity Method InvestmentsUSD | -193,000Source | -96,000Source | -47,000Source | -35,000Source |
| Income Tax Expense (Benefit)USD | 0Source | -2,108,000Source | 83,000Source | 76,000Source |
| Net Income (Loss) Attributable to ParentUSD | -68,943,000Source | -57,829,000Source | -45,892,000Source | -2,006,000Source |
| Nonoperating Income (Expense)USD | -2,575,000Source | -1,390,000Source | 1,180,000Source | 2,455,000Source |
| Operating ExpensesUSD | 66,500,000Source | 58,951,000Source | 49,395,000Source | 46,042,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -5,000Source | 446,000Source |
| Proceeds from Issuance of Common StockUSD | 9,207,000Source | 69,261,000Source | 34,811,000Source | — |
| Proceeds from Issuance of Long-term DebtUSD | — | 9,850,000Source | 9,855,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 133,000Source | 804,000Source | 393,000Source | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 325,000Source | 500,000Source | 2,453,000Source | 41,692,000Source |
| Operating Income (Loss)USD | -66,175,000Source | -58,451,000Source | -46,942,000Source | -4,350,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -5,000Source | 446,000Source |
| Income Tax Expense (Benefit)USD | 0Source | -2,108,000Source | 83,000Source | 76,000Source |
| Net Income (Loss) Attributable to ParentUSD | -68,943,000Source | -57,829,000Source | -45,892,000Source | -2,006,000Source |
| Earnings Per Share, BasicUSD per share | -1.53Source | -1.77Source | -2.17Source | -0.11Source |
| Earnings Per Share, DilutedUSD per share | -1.53Source | -1.77Source | -2.17Source | -0.11Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 45,031,000Source | 32,756,000Source | 21,102,000Source | 18,157,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 45,031,000Source | 32,756,000Source | 21,102,000Source | 18,157,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 205,000Source | 182,000Source | 170,000Source | 163,000Source |
| General and Administrative ExpenseUSD | 16,985,000Source | 14,551,000Source | 13,617,000Source | — |
| Income (Loss) from Equity Method InvestmentsUSD | -193,000Source | -96,000Source | -47,000Source | -35,000Source |
| Interest ExpenseUSD | 2,674,000Source | 1,506,000Source | — | — |
| Investment Income, NetUSD | 99,000Source | 116,000Source | 1,185,000Source | 2,009,000Source |
| Nonoperating Income (Expense)USD | -2,575,000Source | -1,390,000Source | 1,180,000Source | 2,455,000Source |
| Operating ExpensesUSD | 66,500,000Source | 58,951,000Source | 49,395,000Source | 46,042,000Source |
| Research and Development ExpenseUSD | 49,515,000Source | 44,400,000Source | 35,778,000Source | 33,183,000Source |